Spantide II, a novel tachykinin antagonist having high potency and low histamine-releasing effect
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Regulatory Peptides
- Vol. 31 (1) , 75-82
- https://doi.org/10.1016/0167-0115(90)90197-5
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Intranigral substance P stimulation of striatal dopamine release is inhibited by Spantide II: a new tachykinin antagonist without apparent neurotoxicityBrain Research, 1990
- The specific antagonistic effect of intrathecal spantide II on substance P- and C-fiber conditioning stimulation-induced facilitation of the nociceptive flexor reflex in ratBrain Research, 1990
- Neurogenic inflammationTrends in Pharmacological Sciences, 1984
- Sir Thomas Lewis's nocifensor system, histamine and substance-P-containing primary afferent nervesTrends in Neurosciences, 1983
- Substance P antagonists release histamine from peritoneal mast cellsActa Physiologica Scandinavica, 1983
- Substance P-antagonists: a new type of pharmacological toolTrends in Pharmacological Sciences, 1982
- Lntrathecal (D-Pro2, D-Trp7,9)-SP elicits hypoalgesia and motor blockade in the rat and antagonizes noxious responses induced by substance PActa Physiologica Scandinavica, 1982
- pA2 and receptor differentiation: A statistical analysis of competitive antagonismLife Sciences, 1979
- Synthesis and Biological Activity of Analogs of Substance P, Modified for Conformational Information by D-Amino Acids.Acta Chemica Scandinavica, 1979
- QUANTITATIVE STUDIES WITH MAST CELLSAnnals of the New York Academy of Sciences, 1963